Veterinary News - Everost and Spectrum lines of veterinary orthopedic implants and instruments join the Movora portfolio. | Movora
The MedTech division of Vimian Group has added two new lines of veterinary orthopedic implants and instruments to their growing product portfolio.
(ST. AUGUSTINE, FL. APRIL 13, 2022) — Vimian Group’s MedTech segment, Movora, has acquired two product portfolios of veterinary surgical instruments and orthopedic implants sold to veterinary clinics across North America under the brands Spectrum™ and Everost™. The acquisition is a carve-out from a healthcare company and provides a wide range of high-quality veterinary orthopedic implants and surgical instruments developed specifically for veterinary applications.
“This acquisition marks our entry into a new product category with veterinary surgical instrumentation and expands our portfolio of high-quality orthopedic implants. We foresee significant synergy potential as we integrate these product portfolios into our commercial infrastructure around the world and are thrilled to offer veterinary professionals an even more diverse line of the solutions they need for their practice,” says Patrick Gendreau, Co-CEO of Vimian’s MedTech segment Movora.
For the past 30 years, Movora’s family of brands have been committed to the advancement of veterinary orthopedics and have made it their mission to support veterinary professionals across the globe with industry-leading orthopedic solutions and best-in-class service and support. The addition of the Everost and Spectrum lines into their portfolio will help ensure general practitioners and veterinary surgeons have access to the products and clinical support they need to achieve the best outcome for their patients.
“We are excited to welcome both Everost and Spectrum Instruments and look forward to providing veterinarians the opportunity to purchase these products directly from Movora in every market we serve. Teams on both sides are working to make the transition as seamless as possible during the changeover period. Once complete, customers can enjoy ordering these products online along with the thousands of other product solutions offered to Movora customers. And if you need a little guidance, you can count on a friendly account specialist to assist with finding the best solution for the best outcome,” says Korrie Wilhelm, EVP Movora North American HQ and US Distribution Center.
The Everost and Spectrum products will be available for purchase through Movora US and Movora Canada beginning May 2, 2022.
For further information, please contact
Press@movora.com
+1 904.436.6540
About Movora
Movora is a global provider of orthopedic implants sold to veterinarians, veterinary surgeons, and universities. Through its brands, BioMedtrix, Everost, KYON, IMEX Veterinary, Spectrum Instruments, and Veterinary Orthopedic Implants, it offers one of the broadest product portfolios within companion animal orthopedics, ranging from fracture plates to complete hip replacement systems. Movora also believes in supporting veterinary professionals throughout their careers and offers one of the most comprehensive calendars of Continuing Education courses in the industry, teaching DVMs and Veterinary Surgeons new techniques and procedures. Movora has regional headquarters in Florida, USA; Ontario, Canada; Zurich, Switzerland; and Tokyo, Japan. Learn more by visiting movora.com.
About Vimian
Vimian is a global, fast-growing group of innovation-driven companies with a shared passion for making a positive impact through improving animal health. Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to veterinary professionals, labs and pet parents around the world. We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact by improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies reach over 15,000 customers in +150 markets, employ more than 450 people and have a combined annual turnover of approximately EUR 140 million. FNCA Sweden AB is appointed the Company’s Certified Adviser, info@fnca.se, +46 (0) 8-528 00 399. For more information, please visit: www.vimian.com.
For more information about Vimian:
Maria Dahllöf Tullberg
Head of IR & Communications, Vimian
maria.tullberg@vimian.com
+46 736 26 88 86
